Treace Medical Concepts, Inc. provided revenue guidance for the full year 2022. The company expects revenue for the full year 2022 to range from $125 million to $130 million, which represents approximately 32% to 38% growth over the company's 2021 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.05 USD | +0.83% |
|
+2.37% | -52.55% |
05-29 | Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing | MT |
05-17 | North American Morning Briefing : The "Everything -2- | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.55% | 375M | |
+75.67% | 12.57B | |
-25.35% | 7.28B | |
+15.77% | 7.2B | |
+14.52% | 5.47B | |
-20.31% | 4.73B | |
+14.91% | 4.09B | |
-23.83% | 3.78B | |
-30.22% | 2.63B | |
+42.93% | 2.3B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2022